[Cinobufagin treatment of relapsed or refractory hematological malignant tumor: 8 cases report and literatures review]
Zhonghua Xue Ye Xue Za Zhi
.
2015 Nov;36(11):954-6.
doi: 10.3760/cma.j.issn.0253-2727.2015.11.014.
[Article in Chinese]
Authors
Lu Wang
1
,
Ruihua Mi
1
,
Xudong Wei
1
,
Lin Chen
1
,
Hao Ai
1
,
Qingsong Yin
1
,
Ping Wang
1
Affiliation
1
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450000, China.
PMID:
26632471
PMCID:
PMC7342419
DOI:
10.3760/cma.j.issn.0253-2727.2015.11.014
No abstract available
Publication types
Case Reports
Review
MeSH terms
Bufanolides / therapeutic use*
Hematologic Neoplasms / drug therapy*
Humans
Recurrence
Substances
Bufanolides
cinobufagin
Grants and funding
基金项目:国家自然科学基金(81170520)